Top Markets
#1 Black Phoenix Black Phoenix +826.83%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.73%
#3 Beam Beam +24.43%
#4 Tutorial Tutorial +24.34%
#5 Not in Employment, Education, or Training Not in Employment, Education, or Training +21.60%
#6 SAFEcoin SAFEcoin +20.63%
#7 Bless Bless +17.83%
#8 THORChain THORChain +16.01%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +15.60%
#10 EfficientFrontier EfficientFrontier +14.37%
Coin of the day
Black Phoenix Black Phoenix
設定
言語
日本
通貨
USD
テーマ
Kailera Therapeutics, Inc. Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc.

KLRA
株式のランク #5874
Kailera Therapeutics is a biopharmaceutical company currently advancing through... Kailera Therapeutics is a biopharmaceutical company currently advancing through its clinical development stage, dedicated to cultivating a varied portfolio of cutting-edge treatments. These therapeutics are specifically engineered to tackle obesity and its associated metabolic disorders. The company distinguishes itself through its focus on innovative methodologies, offering both injectable and orally administered formulations for sustainable weight management. Its most advanced candidate is a groundbreaking dual-action gut hormone receptor agonist, which has reported encouraging outcomes in its initial clinical investigations.
株価
$18.07
時価総額
$2.34B
変化（1日）
-2.01%
変化（1年）
-
国
US
取引 Kailera Therapeutics, Inc. (KLRA)

カテゴリー

Healthcare
Kailera Therapeutics, Inc.（KLRA）の収益
Aug 2026 時点の収益 TTM: 0
Kailera Therapeutics, Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Kailera Therapeutics, Inc. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH